Our end-goal is to improve patients’ quality of life with our innovative cardiac regenerative technology.
We believe major breakthroughs that improve patient outcomes are achieved through multidisciplinary collaborations.
This is why we have selected partners, advisors and investors who combine their expertise to make regeneration a new paradigm in cardiology with a relentless focus on quality and efficiency.
Current Support for Regencor includes SBIR funding from the Department of Health and Human Services, NIH.
Nodes Advisors are a corporate finance firm committed to advancing the field of Life Sciences through advisory and capital raise.